PROFESSSOR JEAN-PIERRE PELLETIER, M.D. is Professor of Medicine, Accredited Member of the Department of Pharmacology, Director and Co-founder of the Osteoarthritis Research Unit at the University of Montreal Hospital Centre (CHUM). The Osteoarthritis Research Unit is one of the most highly renowned and respected facilities of its kind. He is also co-titular head of the Chair in Osteoarthritis at the University of Montreal.Professor Pelletier is an internationally renowned and respected expert in the field of osteoarthritis. His principal research interest lies in understanding the mechanisms involved in the pathophysiology of osteoarthritis in humans and preclinical models, as well as in investigating and developing new therapeutic strategies to counteract the disease through basic and clinical research. He also developed, with his team, new automated magnetic resonance imaging systems for the quantification of knee and hip structural alterations in humans and animals and uses these methodologies in clinical trials. His work in the field of arthritis research has led to a large number of landmark studies and in turn to major breakthroughs and discoveries with regard to the pathophysiology and treatment of musculoskeletal diseases.Winner of several international and national awards and prizes including the Roger Demers award in 2012 and the prestigious King Faisal International Prize for Medicine in 2010. He was inducted as a “Master” of the American College of Rheumatology (ACR) in 2014 and appointed “fellow” by the Canadian Academy of Health Sciences (CAHS) in 2008. The success of his work is also illustrated by the impressive number of publications, over 485, and abstracts (more than 870) in world-renowned, peer-reviewed journals, and numerous guest speaker appearances.
Prof. Bernard Combe is Professor of Rheumatology at Montpellier University, France, and Head of the Bone and Joint Department at Montpellier University Hospital.
He completed his medical education at Montpellier University and was subsequently awarded a research fellowship in clinical immunology at the University of Texas, San Antonio, USA.
Prof. Combe was elected member of the National Board of Universities (Rheumatology) from 1994–2000 and again from 2006, as well as being president from 2010–2013. He is an active member of numerous EULAR and ACR task forces. Prof. Combe is Editor-in-Chief of RMD Open (EULAR / BMJ journal) and of La Lettre du Rhumatologue. In addition, he is a member of the editorial boards of Annals of Rheumatic Diseases, Arthritis and Rheumatism and Joint Bone Spine. Prof. Combe has co-authored more than 315 articles published in international
peer-reviewed journals, and has been a coordinator or main investigator in 131 clinical trials.
Prof. JOHANNE MARTEL-PELLETIER, Ph.D. is Professor of Medicine in the Department of Medicine and Accredited Member of the Department of Pharmacology at the University of Montreal. In 1981, she co-founded with Professor Jean-Pierre Pelletier, the Osteoarthritis Research Unit at the University of Montreal Hospital Centre, which today is world renowned for its research in the field. In 2000, they initiated a University Chair in Osteoarthritis at the University of Montreal and have been appointed titular heads of this Chair.Her research interests lie in the mechanisms involved in the etiology of osteoarthritis, such as joint tissue catabolism and cartilage repair, the molecular and biochemical mechanisms involved during the osteoarthritis process of certain proteases, pro- and anti-inflammatory factors, and growth factors in humans and targeting new therapeutic strategies for the treatment of osteoarthritis. In addition, she is involved in developing systems using magnetic resonance imaging technology for the automatic quantification of structural tissue changes in the human knee and hip.She is an active member of several editorial boards and committees and is a highly respected reviewer for numerous rheumatology and connective tissue journals and governmental and private research funding agencies at national and international levels. She has authored more than 410 publications including journal articles, reviews and book chapters and over 730 abstracts, as well as being guest editor of several journals and editor of four books. In addition, she has been an invited guest speaker at numerous national and international meetings and conferences. She is recipient of several distinguished scientific awards honouring her excellence and outstanding achievements in osteoarthritis research.
Prof. Boulos Haraoui, MD FRCPC is an Associate Professor of Medicine at the Université de Montréal and head of the Clinical Research Unit in Rheumatology at the Centre hospitalier de l’Université de Montréal (CHUM) and the Institut de rhumatologie de Montréal.
Dr Haraoui received his medical degree from St. Joseph University in Beirut, Lebanon. Following his post graduate training in Internal Medicine and Rheumatology at the University of Montreal, he completed a research Fellowship at the Arthritis Branch of the National Institutes of Health in Bethesda, Maryland.
He is a founding member and vice-chairman of the Canadian Rheumatology Research Consortium (CRRC). He also chairs the Canadian Initiative in Outcomes in Rheumatology Care (CIORA), the research granting committee of the CRA
Doctor Haraoui is a Past-Chairman of the Scientific Committee of the Canadian Rheumatology Association.
He was an examiner for the Royal College of Physicians and Surgeons of Canada and a member of the Subspecialty Committee on Rheumatology of the RCPSC. He is also a past chairman of the Laurentian Conference of Rheumatology
Doctor Haraoui serves on several provincial, national and international educational and advisory committees, especially on issues pertaining to the diagnosis and management of rheumatoid arthritis.
Dr. Jordi Monfort Faure Graduated in Medicine at the Universitat Central de Barcelona, Specialty Registrar of Rheumatology, Parc de Salut Mar. Hospital del Mar Barcelona, Master in Biomedical Sciences, Université de Montréal, Profeciency University of McGill. Montreal, Master in hospital management International University of Catalonia, PhD, Universitat Autonòma de Barcelona 2010-2013
He is currently an Associated Professor of Rheumatology Universitat Autònoma de Barcelona
Dr. Mohit Kapoor is the Director of the Arthritis Research Program (the largest multidisciplinary Arthritis Research Program in Canada) at the Krembil Research Institute and Toronto Western Hospital, University Health Network (Toronto), where he is directing basic, clinical, and translational research in multiple arthritis diseases. He is also the Director of Cartilage Biology and Joint Restoration Therapeutics within the Arthritis Program at the University Health Network. Dr. Kapoor’s translational research program is directed towards: (1) Understanding the complex cellular and molecular mechanisms associated with joint destruction during osteoarthritis; (2) Identifying reliable biomarkers for early identification of patients with osteoarthritis to enable early intervention; (3) Identifying novel therapeutic targets to stop/delay osteoarthritis and restore joint function. His research is funded by various research organizations including the Canadian Institute of Health Research (CIHR), Canadian Foundation for Innovation (CFI), Natural Sciences and Engineering Research Council of Canada (NSERC), Krembil Foundation, The Arthritis Society, Stem Cell Network, etc. He also sits on review panels & boards of various research/funding organizations across the globe.
Tore K. Kvien, MD, PhD has been head of the Department of Rheumatology at Diakonhjemmet Hospital, Oslo, Norway since 1994 and professor of rheumatology at the University of Oslo since 1997. Throughout his career, Professor Kvien has made major contributions to the development and validation of important tools for the assessment of rheumatic diseases (patient-reported outcomes, clinical measures and tools based on imaging modalities).
Professor Kvien has been author on about 500 peer-reviewed publications. He has been editor-in-chief of Annals of Rheumatic Diseases since 2008, was president of the European League Against Rheumatism (EULAR) from 2005 to 2007 and has been the principle investigator of the Norwegian government financed biosimilar switching study (NOR-SWITCH).
Kevin Pile is the current Past President of APLAR, having served previously as Secretary-General, Treasurer, and President. He is also a past Secretary of the Australian Rheumatology Association. He is a graduate of the University of Otago, who completed his MD research at the University of Oxford. He has held senior academic positions in the University of Adelaide and James Cook University. He is currently Director of Medicine at Campbelltown Hospital Sydney and Conjoint Professor of Medicine at Western Sydney University. Recent research activities relate to quality of life in gout patients and pharmacokinetic studies of febuxostat with varying renal function.
Scientific Program Committee
Dr. Laniyati Hamijoyo is a rheumatology consultant in Internal Medicine Department, Faculty of Medicine University of Padjadjaran Bandung, Indonesia. She completed her fellowship training in Rheumatology at the University of Santo Tomas (UST) Hospital, Manila, Philippines.
She is a member of Asia Pacific Lupus Collaboration (APLC), Lupus special interest group (SIG) of Asia Pacific League of Associations for Rheumatology (APLAR) and Indonesia Rheumatology Association (IRA), and also served as scientific committee of APLAR (2016-2018). She actively involves in several national or international clinical trials. She has done several studies, been author and co-author of several journals and books. She is also actively involved in medical education, physician supervision and lay education programs.
Prof. Rohini Handa is currently Senior Consultant Rheumatologist at the Apollo Hospitals, New Delhi, India. He has earlier served on the faculty of the All India Institute of Medical Sciences for over two decades. Prof. Handa is the Dean of the Indian College of Physicians. He has served as President of APLAR (Asia Pacific League of Associations for Rheumatology) and as the Chair of ILAR (International League of Associations for Rheumatology) in 2012. He was the President of the Indian Rheumatology Association from 2009-2011. He has authored/co-authored more than 335 papers, book chapters, review articles and abstracts in national and international journals.
Dr. SA Haq, Professor, Department of Rheumatology, Bangabandhu Sheikh Mujib Medical University (BSMMU) established the first Rheumatology Clinic of the country in October 1991. He was one of the co-founders of Bangladesh Rheumatology Society in 1997 and now is its Senior Vice President. In June 2000, as Chief Investigator, he founded the COPCORD Study Group in Bangladesh. The group has completed stage I COPCORD study and is carrying out stage II and III activities. He became Professor of Medicine (Rheumatology) in July 2001and Professor of Rheumatology in July 2006. He was awarded Fellowship of the Royal College of Physicians of Edinburgh in 2003 and International Fellowship of the American College of Rheumatology in 2005. Dr. Haq’s areas of academic interest include Epidemiology of rheumatic disorders, knee OA and SLE. He has 160 publications in local and international journals out of which 85 are originals. He was awarded a Gold Medal by “Bangladesh Academy of Sciences” for contribution to the advancement of Science in the country. He has served Asia-Pacific League of Associations for Rheumatology (APLAR) in the capacities of APLAR-COPCORD (Community Oriented Program for Control of Rheumatic Disorders) coordinator, Vice President and Treasurer. Currently, Dr. Haq is holding the positions of President Elect of APLAR.
Dr. Graeme Jones attended Sydney University graduating with first class honours in Medicine in 1985. He then did training in Internal Medicine and Rheumatology in Sydney and Newcastle. He became a fellow of the Royal Australasian College of Physicians in 1991. While at Newcastle he also did a Masters degree in Clinical Epidemiology. He then moved to the Garvan Institute in Sydney where he completed a doctorate in Osteoporosis Epidemiology in 1994. He is also a fellow of the Australian faculty of Public Health Medicine. Since 1995 he has been in Hobart, Tasmania where he combines clinical practice and research. He is currently Professor of Rheumatology and Epidemiology and Head of the Musculoskeletal Unit at the Menzies Research Institute as well as Head of the Department of Rheumatology at Royal Hobart Hospital. An NHMRC Practitioner Fellowship funds his position. He is also the current Medical Director of the Arthritis Foundation of Australia. He has received grants from competitive and non-competitive sources totalling over $16 million dollars and has published >250 articles primarily on the epidemiology of osteoporosis and osteoarthritis. In more recent years he has concentrated on both industry sponsored and investigator initiated clinical trials. He has received awards and given numerous oral presentations at the annual scientific meetings of the American Society for Bone and Mineral Research, the American College of Rheumatology, OARSI and EULAR. His current research interests are the development of peak bone mass and fracture aetiology in children, genetic and environmental risk factors for osteoarthritis, health promotion, the role of environmental factors such as diet and physical activity in osteoporosis and fractures in the elderly, clinical trials and meta-analysis.
Professor CS Lau is Chair and Daniel CK Yu Professor in Rheumatology and Clinical Immunology of the Department of Medicine, the University of Hong Kong. He is also Associate Dean (Teaching & Learning) and Director of the Bau Institute of Medical and Health Sciences Education of the Li Ka Shing Faculty of Medicine, the University of Hong Kong, as well as President of the Hong Kong Academy of Medicine. Professor Lau is currently Guest Professor of the Central South University and Honorary Professor of the Peking Union Medical College Hospital of China.
Professor Lau has made significant contribution to the development of Rheumatology locally and internationally. He is Honorary Consultant and Chief of the Division of Rheumatology and Clinical Immunology, which was voted APLAR Center of Excellence in 2016, at Queen Mary Hospital. Professor Lau was also President of the Hong Kong Society of Rheumatology (1997-2001), Chairman of the Subspecialty Board in Rheumatology/Immunology & Allergy of the Hong Kong College of Physicians (2001-2007) and Founding Chairman of the Hong Kong Arthritis & Rheumatism Foundation (2001). Regionally, he co-founded the Hong Kong-Guangzhou Rheumatology Study Group (1998), Huaxia Congress on Diagnosis and Management of Rheumatic Diseases (1999), Asian Congress of Autoimmunity (2005), Ten Topics in Rheumatology in Asia (2008) and the Asia Pacific Lupus Collaboration (2012). Between 2006 and 2008, Professor Lau was President of APLAR (Asia Pacific League of Associations of Rheumatology). He was instrumental in facilitating the success of indexing APLAR’s own journal – the International Journal of Rheumatic Diseases, in PubMed. In 2015, he led the development of APLAR’s first ever treatment recommendations for rheumatoid arthritis.
Professor Lau received his MBChB degree and MD with Honours from the University of Dundee. He is a Fellow of the Royal Colleges of Physicians of Edinburgh, Glasgow and London, as well as the Hong Kong College of Physicians and Hong Kong Academy of Medicine. He is Honorary Fellow of the Academy of Medicine Singapore, American College of Physicians, College of Physicians Singapore and Royal College of Physicians of Thailand.
Zhan-Guo Li, China
Jose Paulo P. Lorenzo is currently Chief of the Section of Rheumatology at Makati Medical Center, he also holds the position of Rheumatology Consultant at both Asian Hospital and Medical Center, Makati Medical Center and University of the Philippines – Philippine General Hospital (UP-PGH) all located in Metro Manila, Philippines.
Dr. Lorenzo graduated with a Doctor of Medicine from UP in 1988 and completed both the US and Philippine Medical Licensure Exam. He was a Clinical/Research Fellow at the eDivision of Rheumatology in the Department of Medicine at Medical College of Wisconsin Affiliated Hospitals, WI, USA from 1994–1997 before returning to practice in the Philippines. Dr Lorenzo is certified by both the Philippine Subspecialty Board of Internal Medicine and the Board of Rheumatology.
Dr. Lorenzo is a Fellow of the Philippine Rheumatology Association and the Philippine College of Physicians. He also holds membership of the UP Medical Alumni Society. Dr Lorenzo has been a Principle Investigator in clinical trials assessing novel pharmacotherapies for the treatment of rheumatoid arthritis and systemic lupus erythematosus
Worawit Louthrenoo, Thailand
Yeong Song, Korea
TSUTOMU TAKEUCHI, M.D., Ph.D.PRESENT
Division of Rheumatology,
Department of Internal Medicine,
Keio University School of Medicine
Professor of Internal Medicine,
Chief of Rheumatology,
Vice dean, Keio University School of Medicine (October, 2011~Semptember, 2013)
General Director of Keio University Hospital
(October 1st, 2013~present)Keio University School of Medicine
35 Shinanomachi, SHINJYUKU,
TOKYO 160-8582, JAPANEDUCATION
Keio University, Faculty of Medicine, MD 1980
Keio University, Faculty of Medicine, PhD 1984TRAINING
INTERNSHIP & RESIDENCES
1980-1983: Resident on Internal Medicine, Keio University HospitalRESEARCH FELLOWSHIP
1980-1984: Clinical and research fellow, Division of Rheumatology and Clinical Immunology, Keio University
1985-1986: Research Fellow, Tumor Immunology
(Prof. Stuart F. Schlossman), Dana-Farber Cancer InstituteACADEMIC APOINTMENTS
1984-1985: Research associate, Rheumatology/Clinical Immunology, Keio University Faculty of Medicine
1986-1988: Associate of Medicine, Saitama Medical University
1989-1992: Assistant Professor of Medicine, Saitama Medical University
1993-1998: Associate Professor of Medicine, Saitama Medical University
1998-2009: Professor of Medicine, Saitama Medical University
2004-2009: Vice dean of Saitama Medical University
2009-present: Professor of Rheumatology, Department of Internal Medicine, Keio University School of Medicine
October, 2011-September, 2013: The assistant dean, Keio University School of Medicine
0ctober, 2013~present: General Director, Keio University Hospital
August, 2014~September, 2015: Chief of Clinical and Translational Research Center, Keio University HospitalOTHER PROFESSIONAL POSITIONS
1992-: Visiting Assistant professor of Medicine, Tokyo
1993-1995: Visiting Associate Professor of Medical Research Institute, Tokyo Medical and Dental University
1996-2009: Visiting Assistant professor of Medicine, Keio University, School of Medicine
2009-present: Visiting Professor of Medicine, Saitama Medical University
Lai-Shan Tam, MD, is division head and a professor in the Division of Rheumatology within the Department of Medicine and Therapeutics at The Chinese University of Hong Kong (CUHK). Dr Tam has been serving as the chairperson of the international affair committee of Asia Pacific League Against Rheumatism (APLAR) since 2012 and the EULAR Programme Committee since Mar 2016. Dr Tam was the Vice President of APLAR between 2014-2016, and served as members of the International Task Force subcommittee and the Membership Task Force subcommittee of ACR before.
Prof. Deven Taneja
MBBS, D.orth, MS orth, FAMS, FRCS ( Eng.)Prof. Taneja is past president of Indian Orthopaedic Association and Orthopaedic Association of SAARC Countries. He is Secretary General of World Orthopaedic Concern, Secretary of Orthopaedic Research and Education Foundation – India. He has more than 50 years experience. He retried as Dean and Prof. of Orthopaedics from Indore University. He has received many International and National awards. Edited 15 books, delivered many orations & guest lectures. At present he is Medical Director at Arihant Hospital & RC, Indore
Wen-Chan Tsai is chief of Rheumatology at the Kaohsiung Medical University Hospital, Taiwan, director of department of laboratory medicine at Kaohsiung Medical University Hospital in Kaohsiung, Taiwan and also secretary general of Asia Pacific League of Associations for Rheumatology (APLAR).
Dr Tsai obtained his medical degree in 1982 from the Kaohsiung Medical University, Taiwan. Subsequently, he underwent residency training in the same institute to become a specialist in internal medicine in 1989 and specialist in rheumatology in 1991. He also earned a PhD in in 2002 from the University of Medical Research, Kaohsiung Medical University, Taiwan. From 1996 to 1997, Dr Tsai underwent post-doctoral fellowship training at the Department of Rheumatology of the University of California, Los Angeles (UCLA), USA.
From 2003 to 2009, Dr Tsai served as Chief of Rheumatology at the Kaohsiung Medical University Hospital, Taiwan. During that period, he also served as Director of Resident Affairs (until 2007) and, subsequently, as Deputy Director of the Department of Medicine, the Kaohsiung Medical University, Taiwan. From 2007 to 2008, Dr Tsai held the position of Director of Molecular and Cellular Function in Laboratory Medicine at the same institute. In 2009, he became Deputy Superintendent of the Kaohsiung Municipal Ta-Tung Hospital, Taiwan, and has held this position until the present. In 2012, he served as director of department of laboratory medicine and chief of clinical trial center at Kaohsiung Medical University Hospital. In 2015, he also served as chief of rheumatology at Kaohsiung Medical University Hospital. In 2016, he also served as secretary general of APLAR.
Professor Huji Xu is Professor of Medicine in Tsinghua University and Second Military Medical University (SMMU). He is founder Executive Dean of School of Clinical Medicine Tsinghua University and Vice President of Beijing Tsinghua Changgung Hospital Tsinghua University. At present, Prof Xu also chair the Department of Internal Medicine and is head of rheumatology and immunology division in Shanghai Changzheng Hospital affiliated to SMMU
Prof Xu graduated from SMMU where he also completed his residency and internship before he went to Australia to pursue his PhD in rheumatology and clinical immunology. He then worked in Flinders Medical Centre and Queensland Institute of Medical Research. Before he full time returned to China, he was R.D. Wright fellow of Australian National Health & Medical Research Council and Professor in University of Queensland
Kazuhiko Yamamoto graduated from The University of Tokyo School of Medicine in 1977. After finishing his residency in internal medicine and rheumatology, he conducted basic research in Heidelberg. In 1997, he was promoted to be a professor and chairman of Department of Allergy and Rheumatology, The University of Tokyo. In 2017, he reached the mandatory retirement age of the University and moved to RIKEN Center for Integrative Medical Sciences as a deputy director. He is now planning to establish a research system of human immunology.
Dr Yeap is a Consultant Rheumatologist at Subang Jaya Medical Centre, Selangor, Malaysia. Her previous appointments include Associate Professor and Head of the Rheumatology Unit at the Department of Medicine, University Malaya.
She is the current Vice-President of the Malaysian Osteoporosis Society and its Immediate Past President, a Past President of the Malaysian Society of Rheumatology, and was previously a Vice-President of the Asia-Pacific League of Associations for Rheumatology (APLAR).
Her research interests focus on osteoporosis, rheumatoid arthritis and systemic lupus erythematosus.